Hypertrophic cardiomyopathy (often called HCM) is an inherited heart condition most commonly associated with thickening (hypertrophy) of a portion or the entire heart muscle. It often affects young individuals, who may not have any symptoms and could result in heart failure and sudden death. Patients with HCM have unique needs and require specialized care over a wide range of medical expertise targeted towards relieving symptoms, preventing complications and exploring surgical options.
The recognition of the need for a specialized center to provide these services in a patient friendly, well-coordinated environment has lead to the launch of the Johns Hopkins HCM Center of Excellence. Indeed, several years ago, Hopkins cardiologists pioneered some of the initial study into the physiologic perturbations in HCM.
Read about Dr. Theodore Abraham's work with hypertrophic cardiomyopathy patients in the Spring 2012 issue of The Cardiovascular Report.
The overall goal of this clinic is to offer patients with HCM and their families access to high quality clinical care supported by state of the art technology and research with a view to alleviate symptoms, prolong life and enhance the understanding of HCM, in a single center setting.
We hope to achieve this goal by building a team dedicated to HCM care consisting of master clinicians, experts in multi-modality imaging, skilled interventional and surgical staff, specialists in genetic medicine and innovative researchers.
The clinic hopes to improve the quality of life in HCM patients, provide education about the disease and to support research into better diagnosis techniques and treatments for HCM.
Specific facilities available through the Johns Hopkins HCM Center of Excellence include access to a clinic staffed by specialists in HCM management, echocardiography, magnetic resonance imaging and spectroscopy, genotyping and genetic counseling, non-invasive risk assessment for sudden death, defibrillator implantation, percutaneous alcohol septal ablation, surgical myectomy and cardiac transplantation. All patients and relatives are also offered enrollment in a variety of ongoing research projects.
Theodore P. Abraham, MD, FACC, FASE
Maria Roselle Abraham, MD
Co-Director and Director, HCM Research